←Back to structures
OX458330.1__CAI8716118.1__PHANIE_0130__00013
Bact-VirOX458330.1__CAI8716118.1__PHANIE_0130__00013
Identity
- Accession:
- OX458330 ↗
- Kingdom:
- phage
Quality
72.1
mean pLDDT
Taxonomy
TaxID: 3029265
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 19-66
Domain cluster:
representative
CATH (42)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3dfeA00 | 3.30.70.120 | Alpha Beta › 2-Layer Sandwich › Alpha-Beta Plaits › | 0.86 | 73.0 | 6.13e-01 | 95.8% | 100.0% |
| 2jveA00 | 2.10.60.10 | Mainly Beta › Ribbon › CD59 › CD59 | 0.80 | 66.0 | 5.74e-01 | 89.6% | 91.5% |
| 3tiiA03 | 3.30.1490.20 | Alpha Beta › 2-Layer Sandwich › Dna Ligase; domain 1 › ATP-grasp fold, A domain | 0.74 | 56.0 | 5.10e-01 | 91.7% | 61.5% |
| 4gvbA00 | 3.30.70.440 | Alpha Beta › 2-Layer Sandwich › Alpha-Beta Plaits › Killer toxin KP6 alpha-subunit | 0.73 | 56.0 | 4.88e-01 | 87.5% | 96.1% |
| 2cs4A00 | 3.10.20.90 | Alpha Beta › Roll › Ubiquitin-like (UB roll) › Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1 | 0.72 | 59.0 | 4.76e-01 | 91.7% | 46.3% |
| 1vj2A00 | 2.60.120.10 | Mainly Beta › Sandwich › Jelly Rolls › Jelly Rolls | 0.70 | 48.0 | 3.71e-01 | 85.4% | 30.7% |
| 3au4A02 | 3.10.20.90 | Alpha Beta › Roll › Ubiquitin-like (UB roll) › Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1 | 0.70 | 58.0 | 4.75e-01 | 97.9% | 57.4% |
| 3d82A00 | 2.60.120.10 | Mainly Beta › Sandwich › Jelly Rolls › Jelly Rolls | 0.69 | 48.0 | 3.80e-01 | 85.4% | 34.3% |
| 2uwqA00 | 3.10.20.90 | Alpha Beta › Roll › Ubiquitin-like (UB roll) › Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1 | 0.69 | 55.0 | 4.57e-01 | 89.6% | 50.0% |
| 4p4tA00 | 3.40.50.300 | Alpha Beta › 3-Layer(aba) Sandwich › Rossmann fold › P-loop containing nucleotide triphosphate hydrolases | 0.69 | 54.0 | 3.30e-01 | 89.6% | 14.9% |
| 1rc6A00 | 2.60.120.10 | Mainly Beta › Sandwich › Jelly Rolls › Jelly Rolls | 0.68 | 47.0 | 3.01e-01 | 85.4% | 14.5% |
| 2wfpA01 | 2.60.120.10 | Mainly Beta › Sandwich › Jelly Rolls › Jelly Rolls | 0.67 | 47.0 | 3.72e-01 | 85.4% | 35.7% |
| 1fviA01 | 3.30.1490.70 | Alpha Beta › 2-Layer Sandwich › Dna Ligase; domain 1 › | 0.67 | 51.0 | 4.47e-01 | 87.5% | 55.7% |
| 2n17A00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.67 | 49.0 | 4.79e-01 | 87.5% | 71.4% |
| 1qwrA02 | 2.60.120.10 | Mainly Beta › Sandwich › Jelly Rolls › Jelly Rolls | 0.66 | 46.0 | 3.76e-01 | 81.2% | 38.2% |
| 3laaA00 | 2.150.10.10 | Mainly Beta › 2 Solenoid › Alkaline Protease, subunit P, domain 1 › Serralysin-like metalloprotease, C-terminal | 0.66 | 47.0 | 3.20e-01 | 75.0% | 22.5% |
| 3ttcA01 | 3.90.870.30 | Alpha Beta › Alpha-Beta Complex › DHBP synthase › | 0.66 | 49.0 | 3.22e-01 | 81.2% | 56.6% |
| 2vpvA00 | 2.60.120.10 | Mainly Beta › Sandwich › Jelly Rolls › Jelly Rolls | 0.65 | 45.0 | 3.67e-01 | 83.3% | 36.2% |
| 2rilA00 | 3.30.70.100 | Alpha Beta › 2-Layer Sandwich › Alpha-Beta Plaits › | 0.65 | 46.0 | 3.81e-01 | 77.1% | 51.6% |
| 3tj8A02 | 3.30.70.790 | Alpha Beta › 2-Layer Sandwich › Alpha-Beta Plaits › UreE, C-terminal domain | 0.65 | 53.0 | 4.74e-01 | 97.9% | 89.2% |
| 1pqsA00 | 3.10.20.90 | Alpha Beta › Roll › Ubiquitin-like (UB roll) › Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1 | 0.63 | 47.0 | 4.21e-01 | 87.5% | 54.5% |
| 2r7kA03 | 3.30.1490.20 | Alpha Beta › 2-Layer Sandwich › Dna Ligase; domain 1 › ATP-grasp fold, A domain | 0.63 | 49.0 | 4.64e-01 | 91.7% | 82.0% |
| 3m3gA00 | 2.40.40.10 | Mainly Beta › Beta Barrel › Barwin-like endoglucanases › RlpA-like domain | 0.62 | 51.0 | 3.89e-01 | 93.8% | 50.0% |
| 1txoB00 | 3.60.40.10 | Alpha Beta › 4-Layer Sandwich › Phosphatase 2c; domain 1 › PPM-type phosphatase domain | 0.62 | 49.0 | 3.26e-01 | 95.8% | 96.2% |
| 1wlfA01 | 2.40.40.20 | Mainly Beta › Beta Barrel › Barwin-like endoglucanases › | 0.61 | 48.0 | 4.05e-01 | 87.5% | 63.1% |
| 2epkX01 | 3.30.160.230 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › N-acetyl-beta-d-glucosaminidase | 0.60 | 42.0 | 3.54e-01 | 72.9% | 56.2% |
| 3pihA03 | 3.30.1490.20 | Alpha Beta › 2-Layer Sandwich › Dna Ligase; domain 1 › ATP-grasp fold, A domain | 0.59 | 44.0 | 4.03e-01 | 87.5% | 65.3% |
| 2ic2A00 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.59 | 48.0 | 3.82e-01 | 93.8% | 59.6% |
| 2dt8A01 | 3.40.50.10170 | Alpha Beta › 3-Layer(aba) Sandwich › Rossmann fold › | 0.59 | 47.0 | 3.50e-01 | 97.9% | 32.2% |
| 2j8bA00 | 2.10.60.10 | Mainly Beta › Ribbon › CD59 › CD59 | 0.58 | 48.0 | 4.22e-01 | 95.8% | 89.7% |
| 3fysA01 | 3.40.50.10170 | Alpha Beta › 3-Layer(aba) Sandwich › Rossmann fold › | 0.58 | 46.0 | 3.41e-01 | 97.9% | 43.8% |
| 6nwmA01 | 2.60.120.280 | Mainly Beta › Sandwich › Jelly Rolls › Regulatory protein AraC | 0.58 | 47.0 | 3.38e-01 | 95.8% | 56.1% |
| 6v55A01 | 2.60.120.290 | Mainly Beta › Sandwich › Jelly Rolls › Spermadhesin, CUB domain | 0.58 | 47.0 | 3.61e-01 | 91.7% | 39.3% |
| 1v70A00 | 2.60.120.10 | Mainly Beta › Sandwich › Jelly Rolls › Jelly Rolls | 0.58 | 44.0 | 3.52e-01 | 87.5% | 53.3% |
| 3v10A02 | 2.60.40.740 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.57 | 44.0 | 3.19e-01 | 87.5% | 36.3% |
| 7a1rA01 | 2.60.40.150 | Mainly Beta › Sandwich › Immunoglobulin-like › C2 domain | 0.57 | 46.0 | 3.60e-01 | 97.9% | 45.8% |
| 3glkA03 | 3.30.1490.20 | Alpha Beta › 2-Layer Sandwich › Dna Ligase; domain 1 › ATP-grasp fold, A domain | 0.56 | 41.0 | 4.03e-01 | 89.6% | 74.6% |
| 3jr7A02 | 2.20.28.50 | Mainly Beta › Single Sheet › Rubrerythrin, domain 2 › DegV, N-terminal domain, peripheral subdomain | 0.56 | 41.0 | 4.41e-01 | 79.2% | 100.0% |
| 2rftA02 | 3.90.209.20 | Alpha Beta › Alpha-Beta Complex › Hemagglutinin (Ha1 Chain); Chain: A; domain 1 › Haemagglutinin, alpha/beta domain, HA1 chain | 0.54 | 44.0 | 2.91e-01 | 100.0% | 68.2% |
| 6x5vA01 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.52 | 38.0 | 3.29e-01 | 91.7% | 50.0% |
| 2vvfA02 | 2.60.120.730 | Mainly Beta › Sandwich › Jelly Rolls › | 0.51 | 42.0 | 3.20e-01 | 95.8% | 78.9% |
| 7l5aA02 | 3.30.450.270 | Alpha Beta › 2-Layer Sandwich › Beta-Lactamase › PHY domain | 0.50 | 37.0 | 2.68e-01 | 83.3% | 26.3% |
ECOD (57)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3708065 | 304.11.1.0 ↗ | a+b two layers › Alpha-beta plaits › Probable ACP-binding domain of malonyl-CoA ACP transacylase › Probable ACP-binding domain of malonyl-CoA ACP transacylase | 0.94 | 81.0 | 6.88e-01 | 91.7% | 100.0% |
| 5059796 | 4326.1.1.0 ↗ | a+b two layers › ERH-like › ERH-like › ERH-like | 0.86 | 71.0 | 6.24e-01 | 89.6% | 66.7% |
| 4934655 | 304.8.1.0 ↗ | a+b two layers › Alpha-beta plaits › ACT-like › ACT-like | 0.86 | 72.0 | 6.01e-01 | 91.7% | 95.0% |
| 4118694 | 304.24.1.0 ↗ | a+b two layers › Alpha-beta plaits › EF-G C-terminal domain-like › EF-G C-terminal domain-like | 0.79 | 62.0 | 5.38e-01 | 87.5% | 98.7% |
| 169110 | 382.1.1.0 ↗ | few secondary structure elements › Snake toxin-like › Snake toxin-like › Snake toxin-like | 0.78 | 64.0 | 5.68e-01 | 91.7% | 91.4% |
| 3218303 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.77 | 56.0 | 5.77e-01 | 87.5% | 84.4% |
| 3176986 | 221.1.1.6 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › RA | 0.77 | 67.0 | 5.52e-01 | 97.9% | 57.6% |
| 3483496 | 386.1.1.0 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers | 0.76 | 65.0 | 6.66e-01 | 97.9% | 100.0% |
| 3164150 | 2006.1.3.1 ↗ | a/b three-layered sandwiches › HAD domain-like › HAD domain-related › Toprim domain › DNA_gyraseB_C,Toprim | 0.76 | 65.0 | 4.20e-01 | 100.0% | 40.9% |
| 3801584 | 221.1.1.6 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › RA | 0.76 | 61.0 | 4.87e-01 | 93.8% | 44.0% |
| 3935405 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.75 | 63.0 | 5.18e-01 | 95.8% | 54.4% |
| 4410550 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.75 | 58.0 | 5.76e-01 | 87.5% | 82.0% |
| 3503544 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.75 | 62.0 | 4.78e-01 | 93.8% | 41.8% |
| 3399988 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.75 | 57.0 | 5.58e-01 | 85.4% | 77.8% |
| 3405569 | 221.1.1.6 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › RA | 0.75 | 62.0 | 4.83e-01 | 95.8% | 47.3% |
| 3993535 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.74 | 60.0 | 5.06e-01 | 89.6% | 53.8% |
| None | — | 0.74 | 58.0 | 3.95e-01 | 89.6% | 42.6% | |
| 3404255 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.74 | 60.0 | 6.00e-01 | 91.7% | 88.0% |
| None | — | 0.74 | 58.0 | 3.24e-01 | 89.6% | 8.4% | |
| 3412052 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.73 | 58.0 | 5.48e-01 | 89.6% | 73.3% |
| 3876105 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.73 | 62.0 | 4.92e-01 | 93.8% | 47.4% |
| 3531085 | 221.1.1.6 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › RA | 0.73 | 61.0 | 4.90e-01 | 93.8% | 47.4% |
| 3738248 | 221.1.1.6 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › RA | 0.73 | 56.0 | 4.88e-01 | 87.5% | 54.7% |
| 3231713 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.73 | 60.0 | 4.98e-01 | 95.8% | 54.4% |
| 3389539 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.73 | 58.0 | 5.91e-01 | 89.6% | 95.6% |
| 3389034 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.72 | 55.0 | 5.38e-01 | 87.5% | 81.8% |
| 3407580 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.72 | 60.0 | 5.35e-01 | 93.8% | 75.7% |
| 4599214 | 221.1.1.73 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › RASSF8-10_RA | 0.72 | 61.0 | 4.76e-01 | 95.8% | 45.7% |
| 3351227 | 2004.1.1.0 ↗ | a/b three-layered sandwiches › P-loop domains-like › P-loop domains-related › P-loop containing nucleoside triphosphate hydrolases | 0.72 | 55.0 | 3.31e-01 | 87.5% | 14.6% |
| 3482400 | 304.9.1.1 ↗ | a+b two layers › Alpha-beta plaits › RNA-binding domain, RBD › RNA-binding domain, RBD › RRM_1 | 0.72 | 50.0 | 4.04e-01 | 75.0% | 78.9% |
| 3377897 | 2004.1.1.0 ↗ | a/b three-layered sandwiches › P-loop domains-like › P-loop domains-related › P-loop containing nucleoside triphosphate hydrolases | 0.72 | 54.0 | 3.09e-01 | 87.5% | 9.2% |
| 4478722 | 304.8.1.5 ↗ | a+b two layers › Alpha-beta plaits › ACT-like › ACT-like › NIL | 0.71 | 57.0 | 4.54e-01 | 93.8% | 84.8% |
| 3964707 | 2006.1.3.0 ↗ | a/b three-layered sandwiches › HAD domain-like › HAD domain-related › Toprim domain | 0.71 | 61.0 | 3.97e-01 | 100.0% | 72.2% |
| 4268493 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.71 | 52.0 | 5.39e-01 | 87.5% | 86.7% |
| 4406660 | 2006.1.3.1 ↗ | a/b three-layered sandwiches › HAD domain-like › HAD domain-related › Toprim domain › DNA_gyraseB_C,Toprim | 0.71 | 60.0 | 3.89e-01 | 100.0% | 37.9% |
| None | — | 0.71 | 60.0 | 3.87e-01 | 100.0% | 37.7% | |
| None | — | 0.71 | 54.0 | 3.03e-01 | 87.5% | 8.4% | |
| 4340143 | 382.1.1.0 ↗ | few secondary structure elements › Snake toxin-like › Snake toxin-like › Snake toxin-like | 0.71 | 56.0 | 5.08e-01 | 91.7% | 95.7% |
| 3916476 | 221.1.1.73 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › RASSF8-10_RA | 0.70 | 59.0 | 4.87e-01 | 93.8% | 52.9% |
| 3395603 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.70 | 58.0 | 4.47e-01 | 93.8% | 41.8% |
| 1401773 | 2004.1.1.0 ↗ | a/b three-layered sandwiches › P-loop domains-like › P-loop domains-related › P-loop containing nucleoside triphosphate hydrolases | 0.70 | 53.0 | 3.31e-01 | 87.5% | 17.2% |
| 164929 | 221.1.1.74 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like › ASPP2-like_RA | 0.69 | 55.0 | 4.57e-01 | 89.6% | 50.0% |
| 3535929 | 386.1.1.248 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › zf-C2H2_ZNF592 | 0.69 | 56.0 | 3.87e-01 | 93.8% | 29.1% |
| 5062217 | 4012.1.1.0 ↗ | a+b two layers › SSHS domain › SSHS domain in type II DNA topoisomerase › SSHS domain in type II DNA topoisomerase | 0.67 | 53.0 | 5.18e-01 | 91.7% | 80.0% |
| 3551383 | 2006.1.3.3 ↗ | a/b three-layered sandwiches › HAD domain-like › HAD domain-related › Toprim domain › Toprim,TOPRIM_C | 0.66 | 54.0 | 3.44e-01 | 100.0% | 34.1% |
| 3390573 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.66 | 50.0 | 4.80e-01 | 89.6% | 86.4% |
| 3389045 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.66 | 49.0 | 4.87e-01 | 89.6% | 80.0% |
| 3970277 | 376.1.1.134 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › NosL | 0.66 | 53.0 | 4.67e-01 | 93.8% | 74.7% |
| 3598323 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.65 | 51.0 | 4.27e-01 | 91.7% | 50.0% |
| 3988217 | 241.12.1.0 ↗ | a+b two layers › Type III secretory system chaperone-like › YktB/PF0168-like › YktB/PF0168-like | 0.64 | 52.0 | 3.51e-01 | 93.8% | 36.5% |
| 4458441 | 2010.1.1.1 ↗ | a/b three-layered sandwiches › EDD domain › EDD domain › EDD domain › DegV | 0.64 | 52.0 | 3.74e-01 | 95.8% | 32.3% |
| 3593119 | 3351.1.1.0 ↗ | a/b three-layered sandwiches › Atg7 N-terminal domain-like › N-terminal domain in E1 enzyme Atg7 › N-terminal domain in E1 enzyme Atg7 | 0.64 | 50.0 | 3.75e-01 | 91.7% | 34.6% |
| 3966404 | 3019.1.1.1 ↗ | beta sandwiches › gp11/flagellar cap protein FliD insertion domain › gp11/flagellar cap protein FliD insertion domain › gp11/flagellar cap protein FliD insertion domain › Flagellin_IN | 0.59 | 47.0 | 3.61e-01 | 91.7% | 81.7% |
| 3969157 | 2010.1.1.1 ↗ | a/b three-layered sandwiches › EDD domain › EDD domain › EDD domain › DegV | 0.57 | 44.0 | 3.20e-01 | 93.8% | 31.2% |
| 3198047 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.57 | 47.0 | 3.79e-01 | 97.9% | 48.6% |
| 4981878 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.55 | 43.0 | 3.88e-01 | 97.9% | 62.9% |
| 3744540 | 221.1.1.0 ↗ | a+b two layers › beta-Grasp › Ubiquitin-related › Ubiquitin-like | 0.53 | 38.0 | 3.32e-01 | 89.6% | 44.2% |